Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Abstract
Vorapaxar is a new oral protease-activated–receptor 1 (PAR-1) antagonist that inhibits thrombin-induced platelet...
Paper Details
Title
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Published Date
Jan 5, 2012
Volume
366
Issue
1
Pages
20 - 33
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History